PETS

PetMed Express, Inc.

$1.21

-3.20%
SectorHealthcareIndustryPharmaceutical RetailersCountryUnited States

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards.

Source: Yahoo Finance
AI summary

Price & performance

1M-11.8%
3M-38.5%
YTD-63.6%
1Y-53.3%
52-week range—
Beta1.07
Full chart and returns against a benchmark

Q-Score

38/ 100

Quality against peers; 50 is the peer median.

Growth32
Risk47
Performance25
Valuation52
Profitability47
Leverage55
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$179M-21.1%
Net income-$57.3M
Net margin-32.0%-29.2 pts
Historical fundamentals

Red flags in filings

5active red flags
Material weakness in controlsJun 2, 2026
Restated financialsOct 7, 2025
Late filing noticeNov 12, 2025
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

PETSIndustryP/E——P/S0.160.35EV/EBITDA——P/B1.142.19PEG——
Dividend yield0.08%
Every valuation metric

Earnings

Nov 10next report, after the close
EPS estimate—
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate